Cleared Special

CardioCel 3D

K170951 · Admedus Regen Pty, Ltd. · Cardiovascular
Apr 2017
Decision
28d
Days
Class 2
Risk

About This 510(k) Submission

K170951 is an FDA 510(k) clearance for the CardioCel 3D, a Intracardiac Patch Or Pledget, Biologically Derived (Class II — Special Controls, product code PSQ), submitted by Admedus Regen Pty, Ltd. (Malaga, AU). The FDA issued a Cleared decision on April 28, 2017, 28 days after receiving the submission on March 31, 2017. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.3470.

Submission Details

510(k) Number K170951 FDA.gov
FDA Decision Cleared SESE
Date Received March 31, 2017
Decision Date April 28, 2017
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PSQ — Intracardiac Patch Or Pledget, Biologically Derived
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.3470
Definition To Repair Defects, To Be Used For Patch Grafting, To Repair Tissue, And To Buttress Sutures In The Heart And Vasculature.

Similar Devices — PSQ Intracardiac Patch Or Pledget, Biologically Derived

All 10
PERI-GUARD Repair Patch, SUPPLE PERI-GUARD Repair Patch
K221029 · Synovis Life Technologies, Inc. · Oct 2022
Vascu-Guard Vascular Repair Patch
K221032 · Synovis Life Technologies, Inc. · Oct 2022
CardiaMend Pericardial and Epicardial Reconstruction Matrix
K210331 · Helios Cardio, Inc. · Dec 2021
ADAPT Tissue
K200566 · Admedus Regen Pty, Ltd. · Apr 2020
XenoSure Biologic Patch
K190882 · Lemaitre Vascular · Feb 2020
MatriStem UBM Pericardial Patch
K191734 · Acell, Inc. · Nov 2019